Hilleman Laboratories
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$32.14M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hilleman Laboratories is a biopharmaceutical company that develops affordable vaccines and biologics for infectious diseases prevalent in low- and middle-income countries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
Nonprofit or NGO
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hilleman Laboratories Comparables
Compare Hilleman Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Access to Advanced Health Institute | 87% | |
| Sabin Vaccine Institute | 80% | |
| Afrigen Biologics and Vaccines | 79% | |
Hilleman Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Corporate Funding | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 | ||||
| Grant | Sep 28, 2017 | ||||
| Joint Venture | Sep 16, 2009 |
Hilleman Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Gates Foundation | Grant |
| Vinnova | Grant |
| Singapore Economic Development Board | Corporate Funding |
| Bill & Melinda Gates Foundation | Grant |
| Wellcome Trust | Joint Venture |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 812% MoM to 3.4K.
- Jan 22, 2026
$30M raised from CEPI
Hilleman Laboratories Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hilleman Laboratories's valuation, stock price, and market status.